Updated ASCO Clinical Practice Guideline includes Breast Cancer Index

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The American Society of Clinical Oncology published an update expanding the utility of Breast Cancer Index, developed by Hologic Inc., within its Clinical Practice Guideline, “Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer.” 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

If you believe in the miraculous healing power of ivermectin, hydroxychloroquine, and the harm from vaccination for HPV and COVID-19, you’ve got a powerful friend in Sen. Ron Johnson (R-WI), chair of the Permanent Subcommittee on Investigations of the Senate Committee on Homeland Security and Governmental Affairs.
In a poignant keynote punctuated with anecdotes about grief, American Society of Clinical Oncology’s immediate past president Eric Small emphasized that the annual conference is not just about scientific discovery, but about a responsibility to translate discoveries into better outcomes for cancer patients globally. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login